This inventor holds 1 USPTO granted patent. Top assignee: International Stem Cell Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovations of Nickolay A. Turovets
Introduction
Nickolay A. Turovets is a prominent inventor based in Carlsbad, California. He has made significant contributions to the field of stem cell research, particularly in the development of patient-specific stem cell lines. His work has the potential to revolutionize regenerative medicine and therapeutic applications.
Latest Patents
Turovets holds a patent for "Patient-specific stem cell lines derived from human parthenogenetic blastocysts." This innovative method involves generating HLA homozygous parthenogenetic human stem cell (hpSC-Hhom) lines from both HLA homozygous and HLA heterozygous donors. The hpSC-Hhom lines exhibit typical human embryonic stem cell morphology, express appropriate stem cell markers, and demonstrate high levels of alkaline phosphatase and telomerase activity. Notably, the injection of these cell lines into immunodeficient animals results in teratoma formation. Furthermore, the protocol minimizes the use of animal-derived components, enhancing the practicality of these stem cells for clinical applications.
Career Highlights
Turovets is associated with International Stem Cell Corporation, where he continues to advance his research in stem cell technology. His work is characterized by a commitment to innovation and the pursuit of solutions that can lead to significant medical breakthroughs.
Collaborations
Throughout his career, Turovets has collaborated with notable colleagues, including Elena S. Revazova and Leonid N. Kuzmichev. These partnerships have fostered a collaborative environment that enhances the research and development of stem cell technologies.
Conclusion
Nickolay A. Turovets is a key figure in the field of stem cell research, with a focus on patient-specific applications. His innovative patent and ongoing work at International Stem Cell Corporation highlight his dedication to advancing medical science. The impact of his contributions is poised to benefit the field of regenerative medicine significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile